CEMPRA INC (CEMP) Stock Price, Forecast & Analysis

NASDAQ:CEMP • US15130J1097

2.325
+0.03 (+1.09%)
At close: Nov 3, 2017
2.295
-0.03 (-1.29%)
After Hours: 11/3/2017, 8:10:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News

CEMP Key Statistics, Chart & Performance

Key Statistics
Market Cap122.09M
Revenue(TTM)15.39M
Net Income(TTM)-76.95M
Shares52.51M
FloatN/A
52 Week High9.4
52 Week Low2.05
Yearly Dividend0
Dividend Yield0%
EPS(TTM)-1.47
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
CEMP short term performance overview.The bars show the price performance of CEMP in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30

CEMP long term performance overview.The bars show the price performance of CEMP in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of CEMP is 2.325 null. In the past month the price decreased by -26.77%. In the past year, price decreased by -69.21%.

CEMPRA INC / CEMP Daily stock chart

CEMP Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
CEMP Full Technical Analysis Report

CEMP Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to CEMP. CEMP scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
CEMP Full Fundamental Analysis Report

CEMP Financial Highlights

Over the last trailing twelve months CEMP reported a non-GAAP Earnings per Share(EPS) of -1.47. The EPS increased by 33.97% compared to the year before.


Industry RankSector Rank
PM (TTM) -499.88%
ROA -42.78%
ROE -53.6%
Debt/Equity 0.03
Chartmill High Growth Momentum
EPS Q2Q%68.2%
Sales Q2Q%-56.77%
EPS 1Y (TTM)33.97%
Revenue 1Y (TTM)-2.96%
CEMP financials

CEMP Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next Y56.92%
Revenue Next YearN/A
CEMP Analyst EstimatesCEMP Analyst Ratings

CEMP Ownership

Ownership
Inst Owners49.36%
Ins Owners7.24%
Short Float %N/A
Short RatioN/A
CEMP Ownership

About CEMP

Company Profile

Cempra Holdings, LLC is a pharmaceutical company engaged in developing antibiotics for the treatment of bacterial infectious diseases. It focuses on developing antibiotics for treating respiratory tract, skin and skin structure infections and to target the growing problem of antimicrobial resistance. Cempra Holdings, LLC is headquartered in Chapel Hill, North Carolina.

Company Info

CEMPRA INC

6320 QUADRANGLE DRIVE SUITE 360

CHAPEL HILL NC 27517

CEO: David S. Zaccardelli

Phone: 919-313-6601

CEMPRA INC / CEMP FAQ

What does CEMP do?

Cempra Holdings, LLC is a pharmaceutical company engaged in developing antibiotics for the treatment of bacterial infectious diseases. It focuses on developing antibiotics for treating respiratory tract, skin and skin structure infections and to target the growing problem of antimicrobial resistance. Cempra Holdings, LLC is headquartered in Chapel Hill, North Carolina.


Can you provide the latest stock price for CEMPRA INC?

The current stock price of CEMP is 2.325 null. The price increased by 1.09% in the last trading session.


Does CEMPRA INC pay dividends?

CEMP does not pay a dividend.


How is the ChartMill rating for CEMPRA INC?

CEMP has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Should I buy CEMP stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CEMP.


What is the market capitalization of CEMP stock?

CEMPRA INC (CEMP) has a market capitalization of 122.09M null. This makes CEMP a Micro Cap stock.